Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18322935
[patent_doc_number] => 20230121063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => ONCOLYTIC VIRUS FOR COLORECTAL CANCER TREATMENT USING COLORECTAL CANCER CELL-SPECIFIC INFECTIOUS NEWCASTLE DISEASE VIRUS AND COMPOSITION FOR COLORECTAL CANCER TREATMENT USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/606931
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606931
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606931 | Oncolytic virus for colorectal cancer treatment using colorectal cancer cell-specific infectious newcastle disease virus and composition for colorectal cancer treatment using same | Sep 26, 2021 | Issued |
Array
(
[id] => 17769602
[patent_doc_number] => 11401531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => AAV vectors encoding NF1 and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/483115
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 22568
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483115 | AAV vectors encoding NF1 and uses thereof | Sep 22, 2021 | Issued |
Array
(
[id] => 17334597
[patent_doc_number] => 20220000928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/480919
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480919 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Sep 20, 2021 | Issued |
Array
(
[id] => 17334598
[patent_doc_number] => 20220000929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/480941
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480941
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480941 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Sep 20, 2021 | Issued |
Array
(
[id] => 17334596
[patent_doc_number] => 20220000927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/480916
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480916 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Sep 20, 2021 | Issued |
Array
(
[id] => 17633875
[patent_doc_number] => 11344580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Restimulation of cryopreserved tumor infiltrating lymphocytes
[patent_app_type] => utility
[patent_app_number] => 17/480935
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 41908
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480935 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Sep 20, 2021 | Issued |
Array
(
[id] => 17334595
[patent_doc_number] => 20220000926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/480900
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480900 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Sep 20, 2021 | Issued |
Array
(
[id] => 17482619
[patent_doc_number] => 20220090123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => HIGH THROUGHPUT ASSAY FOR MEASURING ADENOVIRUS REPLICATION KINETICS
[patent_app_type] => utility
[patent_app_number] => 17/459095
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17459095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/459095 | HIGH THROUGHPUT ASSAY FOR MEASURING ADENOVIRUS REPLICATION KINETICS | Aug 26, 2021 | Pending |
Array
(
[id] => 17312841
[patent_doc_number] => 20210401889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/459988
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17459988
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/459988 | Restimulation of cryopreserved tumor infiltrating lymphocytes | Aug 26, 2021 | Issued |
Array
(
[id] => 17670972
[patent_doc_number] => 20220184139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS OF PREPARING AND USING NOVEL STEM CELL COMPOSITIONS AND KITS COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/458083
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458083
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458083 | METHODS OF PREPARING AND USING NOVEL STEM CELL COMPOSITIONS AND KITS COMPRISING THE SAME | Aug 25, 2021 | Pending |
Array
(
[id] => 17503555
[patent_doc_number] => 20220096657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/412592
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17412592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/412592 | COMPOSITIONS FOR THE TREATMENT OF DISEASE | Aug 25, 2021 | Pending |
Array
(
[id] => 17242021
[patent_doc_number] => 20210361764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => POLYMERIC CARRIER CARGO COMPLEX FOR USE AS AN IMMUNOSTIMULATING AGENT OR AS AN ADJUVANT
[patent_app_type] => utility
[patent_app_number] => 17/393362
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17393362
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/393362 | POLYMERIC CARRIER CARGO COMPLEX FOR USE AS AN IMMUNOSTIMULATING AGENT OR AS AN ADJUVANT | Aug 2, 2021 | Pending |
Array
(
[id] => 17414343
[patent_doc_number] => 20220049247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => MATERIALS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 2A AND/OR NON-SYNDROMIC AUTOSOMAL RECESSIVE RETINITIS PIGMENTOSA (ARRP)
[patent_app_type] => utility
[patent_app_number] => 17/391862
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17391862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/391862 | MATERIALS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 2A AND/OR NON-SYNDROMIC AUTOSOMAL RECESSIVE RETINITIS PIGMENTOSA (ARRP) | Aug 1, 2021 | Pending |
Array
(
[id] => 18051766
[patent_doc_number] => 11525139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Compositions and methods for treating non-age-associated hearing impairment in a human subject
[patent_app_type] => utility
[patent_app_number] => 17/378606
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 90656
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378606 | Compositions and methods for treating non-age-associated hearing impairment in a human subject | Jul 15, 2021 | Issued |
Array
(
[id] => 17297856
[patent_doc_number] => 20210393695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES
[patent_app_type] => utility
[patent_app_number] => 17/369831
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/369831 | COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES | Jul 6, 2021 | Pending |
Array
(
[id] => 17199158
[patent_doc_number] => 20210339252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => Microfluidic Delivery Method Utilizing An Electric Field
[patent_app_type] => utility
[patent_app_number] => 17/367619
[patent_app_country] => US
[patent_app_date] => 2021-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367619
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/367619 | Microfluidic delivery method utilizing an electric field | Jul 4, 2021 | Issued |
Array
(
[id] => 17183885
[patent_doc_number] => 20210330770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => Use of Car and Bite Technology Coupled with an SCFV from an Antibody Against Human Thymidine Kinase 1 to Specifically Target Tumors
[patent_app_type] => utility
[patent_app_number] => 17/366708
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366708
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/366708 | Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors | Jul 1, 2021 | Issued |
Array
(
[id] => 17168906
[patent_doc_number] => 20210322576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => SYNTHETIC DNA VECTORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/365808
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365808 | Synthetic DNA vectors and methods of use | Jun 30, 2021 | Issued |
Array
(
[id] => 17227218
[patent_doc_number] => 20210353774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING LEBER?S HEREDITARY OPTIC NEUROPATHY WITH NADH DEHYDROGENASE PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/361884
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17361884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/361884 | Compositions and methods for treating leber's hereditary optic neuropathy with NADH dehydrogenase proteins | Jun 28, 2021 | Issued |
Array
(
[id] => 17385998
[patent_doc_number] => 20220033850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => DESIGN OF BACTERIOPHAGE-BASED ARTIFICIAL VIRUSES FOR HUMAN GENOME REMODELING
[patent_app_type] => utility
[patent_app_number] => 17/359711
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359711
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359711 | Bacteriophage-based artificial viruses for human genome remodeling | Jun 27, 2021 | Issued |